PHARMAGREEN BIOTECH INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-05-18: Form 8-K; Period of report 2023-04-27; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2022-12-02: Form 8-K; Period of report 2022-11-28; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; Details 1.01.
- 2022-08-11: Form 8-K; Period of report 2022-08-01; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2021-08-24: Form 8-K; Period of report 2021-08-24; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2023-05-18 | 8-K | 2023-04-27 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Former Independent Registered Public Accounting Firm. | phbi_8k.htm |
| 2022-12-02 | 8-K | 2022-11-28 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 1.01 Securities Purchase Agreement with JanBella Group, LLC. 3.02 The issuance of a convertible promissory note to JanBella Group, LLC was made to one accredited investor (as that term is defined in Regulation D of the Securities Act of 1933) relying on Rule 506 of Regulation D and/or Section 4 (2) of the Securities Act of 1933. 8.01 On November 28, 2022, the Company entered into a Product Endorsement Agreement with Tyrell Crosby. | phbi_8k.htm |
| 2022-08-11 | 8-K | 2022-08-01 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On August 1, 2022, the Board of Directors accepted the resignation of the Company’s independent registered public accounting firm Saturna Group Chartered Professional Accountants LLP (“Saturna Group” or “Former Auditor”). | phbi_8k.htm |
| 2021-08-24 | 8-K | 2021-08-24 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | phbi_8k.htm |
| 2021-06-23 | 8-K | 2021-06-13 | 1.01 Entry into a Material Definitive Agreement | 1.01 Effective June 13, 2021, the Company entered into a consulting agreement with Milestone Management Services. | 8kpbi.htm |
| 2021-05-17 | 8-K | 2021-05-17 | 1.01 Entry into a Material Definitive Agreement | 1.01 Effective May 14, 2021, the Company entered into a SAAS Agreement with Novation Solutions Inc. (“DealMaker”). | pbi8k.htm |
| 2021-03-22 | 8-K | 2021-03-22 | 8.01 Other Events | 8.01 Pursuant to a Settlement Agreement and Mutual Release dated March 15, 2021, the United States District Court Southern District of New York ordered on March 16, 2021 that the action between EMA Financial, LLC “plaintiff” and Pharmagreen Biotech Inc. “defendant” be dismissed without cost or prejudice to restoring the action to the Court’s calendar provided the application to restore the action is made within thirty (30) days of the Order. | 8kpbi.htm |
| 2020-10-20 | 8-K | 2020-10-19 | 8.01 Other Events | 8.01 On October 19, 2020, Pharmagreen Biotech Inc. announced that it is no longer under chapter 11 proceedings of the U.S. Bankruptcy Code. | 8kpbi.htm |
| 2020-10-16 | 8-K | 2020-10-14 | 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders | 3.02 Unregistered Sales Of Equity Securities. 3.03 Acting pursuant to the authority granted by Sections 78.1955 and 78.315 of the Nevada General Corporation Law, and the Bylaws of the Company, the Company filed a certificate of designation with the Nevada Secretary of State for Series A Super Voting Preferred shares on October 14, 2020. | 8kpbi.htm |
| 2020-08-12 | 8-K | 2020-08-07 | 1.03 Bankruptcy or Receivership; 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement; 7.01 Regulation FD Disclosure; 8.01 Other Events | 1.03 On August 7, 2020, (the “Petition Date”), Pharmagreen Biotech, Inc., Inc. (the “Company” or the “Debtors”), filed voluntary petitions for reorganization (the “Bankruptcy Petitions” and the cases commenced thereby, the “Chapter 11 Cases”) under chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Nevada (the “Court”). 2.04 The commencement of the Chapter 11 Cases described in Item 1.03 of this report constitutes an event of default under certain of the Company’s debt instruments, including various Unsecured Convertible Note Agreements (collectively, the “Unsecured Notes”), which results in automatic acceleration of the Company’s obligations under such debt instruments. 7.01 On August 11, 2020, the Company issued a press release announcing the filing of the Bankruptcy Petitions. 8.01 The Company cautions that trading in the Company’s securities during the pendency of the Chapter 11 Cases is highly speculative and poses substantial risks. | 8kpbi.htm |
| 2020-07-21 | 8-K | 1.01 Entry into a Material Definitive Agreement | 1.01 Effective July 9, 2020, the Company entered into a consulting agreement with Milestone Management Services (“Consultant”). | pgform8k.htm | |
| 2020-05-22 | 8-K | 2020-05-22 | 1.01 Entry into a Material Definitive Agreement | 1.01 Effective January 29, 2020, the Company entered into a listing services agreement with Selected Listings Inc., (“Listing Agent”). | f200522pbiform8k.htm |
| 2020-03-04 | 8-K | 2020-02-28 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Effective January 14, 2020, the Company entered into a securities purchase agreement with CROWN BRIDGE PARTNERS, LLC. 3.02 Unregistered Sales Of Equity Securities. | f200228pbiform8k.htm |
| 2020-01-24 | 8-K | 2020-01-23 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Effective January 2, 2020, the Company entered into a third securities purchase agreement with Power Up Lending Group Ltd. (“Power Up”). 3.02 Unregistered Sales Of Equity Securities. | f200123phgform8k.htm |
| 2019-12-02 | 8-K | 2019-11-29 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On November 22, 2019, Pharmagreen Biotech Inc. (the “Company”) entered into an equity purchase agreement (the “EPA”) with Oscaleta Partners LLC, a Connecticut limited liability company (“Oscaleta”) and a related registration rights agreement (“Registration Rights Agreement”). 3.02 The information set forth in Item 1.01 of this Form 8-K is incorporated into this Item 3.02 by reference. | f191129phgform8k.htm |
| 2019-11-08 | 8-K | 2019-11-08 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Effective September 19, 2019 Pharmagreen Biotech Inc. (“we”, “us”, “our”, the “Company”) entered into a securities purchase agreement dated September 17, 2019 with Power Up Lending Group Ltd. (“Power Up”). 3.02 Unregistered Sales Of Equity Securities. | f191007phgform8k.htm |
| 2019-09-11 | 8-K | 2019-09-11 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 3.02 Unregistered Sales Of Equity Securities. | phgform8k.htm |
| 2010-01-19 | 8-K | 2009-12-24 | 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | g3798.txt | |
| 2009-09-21 | 8-K/A | 2009-08-07 | 4.01 Changes in Registrant's Certifying Accountant | g3476.txt | |
| 2009-09-08 | 8-K/A | 2009-08-07 | 4.01 Changes in Registrant's Certifying Accountant | g3440.txt | |
| 2009-08-12 | 8-K | 2009-08-07 | 4.01 Changes in Registrant's Certifying Accountant | airtransportgrp8k.txt | |
| 2009-03-11 | 8-K | 2009-02-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | g2980.txt | |
| 2009-01-12 | 8-K | 2008-12-31 | 1.01 Entry into a Material Definitive Agreement | g2859.txt | |
| 2008-11-06 | 8-K | 2008-07-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | g2735.txt | |
| 2008-08-04 | 8-K | 2008-07-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | g2481.txt |